In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed the day trading at $12.82 down -9.46% from the previous closing price of $14.16. In other words, the price has decreased by -$9.46 from its previous closing price. On the day, 20.45 million shares were traded. TEVA stock price reached its highest trading level at $13.95 during the session, while it also had its lowest trading level at $12.465.
Ratios:
For a better understanding of TEVA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.20. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.03.
On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.
Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’25 when Daniell Richard sold 70,961 shares for $15.91 per share. The transaction valued at 1,128,642 led to the insider holds 48,384 shares of the business.
Hughes Eric A sold 15,174 shares of TEVA for $238,757 on Mar 04 ’25. The See “Remarks” now owns 8,077 shares after completing the transaction at $15.73 per share. On Mar 05 ’25, another insider, Hughes Eric A, who serves as the See “Remarks” of the company, sold 8,077 shares for $15.91 each. As a result, the insider received 128,531 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 15223749632 and an Enterprise Value of 30877974528. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.89 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 1.866 whereas that against EBITDA is 6.969.
Stock Price History:
The Beta on a monthly basis for TEVA is 0.65, which has changed by -0.036090255 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $12.51. The 50-Day Moving Average of the stock is -20.05%, while the 200-Day Moving Average is calculated to be -27.47%.
Shares Statistics:
Over the past 3-months, TEVA traded about 12.98M shares per day on average, while over the past 10 days, TEVA traded about 14797600 shares per day. A total of 1.15B shares are outstanding, with a floating share count of 1.15B. Insiders hold about 0.02% of the company’s shares, while institutions hold 58.65% stake in the company. Shares short for TEVA as of 1741910400 were 34801653 with a Short Ratio of 2.49, compared to 1739491200 on 26656344. Therefore, it implies a Short% of Shares Outstanding of 34801653 and a Short% of Float of 3.05.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 2.95.
